- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 15.04. | Oryzon Genomics - First patient dosed in iadademstat + ICI SCLC trial | 306 | Oryzon Genomics has announced that the first patient has been dosed in iadademstat's Phase I/II trial, sponsored by the National Cancer Institute, (NCI) in extensive-stage small cell lung cancer (SCLC).... ► Artikel lesen | ||
| 15.04. | Nanoco Group - Encouraging commercial progress | 238 | Nanoco's interim results highlight a number of encouraging developments. All milestones have been achieved with the company's Asian chemicals customer and phase two should start in H225 or H126. Nanoco... ► Artikel lesen | ||
| 15.04. | Freelancer Limited - Positive start to the year | 301 | After reporting positive momentum in Q424, Freelancer saw year-on-year growth in gross marketplace volume (GMV) and revenue in Q125 across both divisions. The company also generated positive operating... ► Artikel lesen | ||
| 14.04. | JDC Group - Operational leverage becoming visible | 617 | JDC Group's (JDC's) final FY24 results were in line with the preliminary numbers published on 10 March. FY24 growth was driven by the platform Advisortech division, but Advisory activities were also... ► Artikel lesen | ||
| 11.04. | Devolver Digital - 2024 in line and 2025 to continue improvements | 334 | Devolver Digital's 2024 FY24 results saw a return to adjusted EBITDA profitability as the company and its peers adjusted to post-pandemic market conditions. The H224 results continued that trend and... ► Artikel lesen | ||
| 11.04. | Ocean Wilsons Holdings - Disposal to generate surplus capital | 320 | In FY24, Ocean Wilsons increased its earnings per share and dividend by 7% and more than 40%, respectively. 2024 was a seismic year for the company as it agreed to sell its 56% holding in Wilson Sons.... ► Artikel lesen | ||
| 10.04. | Sareum Holdings - Broader pipeline, bigger milestones | 254 | Sareum Holdings' H125 results (to 31 December 2024) summarised a period of operational progress and an improved capital position, with successful fund-raising. Since the completion of the Phase I trial... ► Artikel lesen | ||
| 10.04. | Saniona - Broad pipeline to address neurological conditions | 334 | Saniona is a European pioneer in ion channel drug discovery. Internally, it is primarily focused on its preclinical epilepsy pipeline: SAN2355 (for focal/generalised epilepsy) and SAN2219 (for acute... ► Artikel lesen | ||
| 10.04. | SIGA Technologies - Dividends bring cheer amid market uncertainty | 430 | SIGA Technologies has declared a special dividend of $0.6 per share, marking a fourth straight year of dividend declarations. The outlay is at a similar level to the one paid in March 2024 ($43m based... ► Artikel lesen | ||
| 10.04. | Cordel Group - PTC milestones crossed | 307 | Cordel's progress update on its Positive Train Control (PTC) development gives a good indication that the business is on track to open up a significant new revenue opportunity in the North American... ► Artikel lesen | ||
| 08.04. | BlackRock American Income Trust - Proposed change in investment strategy | 330 | BlackRock American Income Trust's (BRAI's) board has proposed a significant and innovative package of changes to adopt a systematic investment approach, which is a first in the investment trust sector.... ► Artikel lesen | ||
| 07.04. | AUSTRIACARD - FY24 net income growth of 20% | 440 | AUSTRIACARD's FY24 adjusted revenue and EBITDA met guidance, although slightly below our forecasts. Document lifecycle management and digital transformation technologies were the key drivers of revenue... ► Artikel lesen | ||
| 04.04. | Northern Data Group - Strategic alliance with Gcore | 1.163 | Northern Data has announced a new strategic partnership with Gcore, a leading provider of edge AI, cloud, network and security solutions. We see this as an important initiative, consistent with management's... ► Artikel lesen | ||
| 04.04. | Mendus (OMX: IMMU) presents DCOne platform update | 337 | On 3 April 2025, Mendus has announced that the company presented data from its proprietary DCOne platform at the Immunotherapy of Cancer Conference. The presentation showcased the potential of the platform... ► Artikel lesen | ||
| 04.04. | Immix Biopharma - All eyes on NEXICART-2 | 377 | Immix's FY24 results summarize a period of focus on its lead CAR-T asset, NXC-201, which is being developed for amyloid light chain amyloidosis. Recent newsflow reflects heightened clinical activity... ► Artikel lesen | ||
| 03.04. | Newron Pharmaceuticals - Pivotal evenamide trial looms | 577 | Newron Pharmaceuticals has published its FY24 results, reflecting a rewarding period for its lead clinical candidate, evenamide, which is being developed for treatment-resistant schizophrenia (TRS).... ► Artikel lesen | ||
| 03.04. | OSE Immunotherapeutics - Primed for value appreciation | 371 | OSE Immunotherapeutics is a clinical-stage immuno-oncology and immuno-inflammation company, with a pipeline spanning all stages of development. The company recently reported its FY24 results, reflecting... ► Artikel lesen | ||
| 03.04. | Moonpig - FY25 update shows continued cash generation | 343 | Moonpig's trading statement for FY25 (to end April) shows that the year looks set to finish in line or slightly better than expected. This is despite a challenging consumer confidence and geopolitical... ► Artikel lesen | ||
| 03.04. | Isofol (ST: ISOFOL) to receive financing to support Phase II & III trials of arfolitixorin in Japan | 292 | Isofol Medical has announced that Solasia Pharma, its development and commercialisation partner in Japan, intends to invest c SEK140m to support planned Phase II and III trials of arfolitixorin in the... ► Artikel lesen | ||
| 02.04. | Quadrise - Making waves | 345 | Quadrise raised £6.5m (before costs) in January through a placing and retail offer, increasing the company's cash reserves to £7.1m as of 28 February 2025. Management stated these funds will support... ► Artikel lesen | ||
| 02.04. | Topps Tiles (LSE:TPT) - volatile but improving trends through Q225 | 348 | Topps Tiles' H125 trading update indicates improving volume and revenue trends through Q225, with an exit rate of high-single-digit revenue growth in March 2025. There is a clear message that the Mission... ► Artikel lesen | ||
| 02.04. | Topps Tiles - Improving revenue growth through Q225 | 306 | Topps Tiles' H125 trading update indicates improving volume and revenue trends through Q225, with an exit rate of high-single-digit revenue growth in March 2025. There is a clear message that the Mission... ► Artikel lesen | ||
| 01.04. | Barton Gold - The Rubicon crossed - marching to production | 1.211 | Barton has continued to aggressively pursue its ambition to produce 125-150koz gold pa at Tunkillia via open pit production, completing a 5,064m reverse circulation drilling campaign targeting block... ► Artikel lesen | ||
| 01.04. | Picton Property Income - Further accretive sale completed | 274 | Picton Property Income (PCTN) has completed the £8.4m disposal of a vacant office building, which is to be redeveloped for student accommodation. The company completed three such sales in FY25, for... ► Artikel lesen | ||
| 01.04. | International Public Partnerships - Further measures to combat the discount | 326 | International Public Partnerships' (INPP's) results for the year ended 31 December 2024 show continuing strong operational performance, underpinning fully covered dividend growth. Primarily reflecting... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .